ACE
(Angio-1 converting enzyme)
Material: | 1 ml serum (Stability in serum at 4° C - 8° C: 7 days) |
Methods: | Spektrometrie → UV- / VIS-Photometrie | Reference range | 20 U/l – 70 U/l |
Indication | Therapy monitoring in case of active sarcoidosis of the lungs, less suitable for differential diagnosis |
Please note | ACE inhibitors such as captopril may lead to decreased levels and should be discontinued 4 weeks prior to the test, where possible. Hemolytic and lipemic samples also lead to decreased ACE-levels. ACE is increased in case of active sarcoidosis and other granulomatous disorders such as silicosis, asbestosis, Gaucher’s disease, tuberculosis, M. Hodgkin, non-Hodgkin-lymphoma, acute and chronic leukemia, multiple myeloma, virus hepatitis, liver cirrhosis, biliary cirrhosis, respiratory distress syndrome of newborns, diabetes mellitus, M. Kaposi, psoriasis vulgaris. |
External services | ja Labor Zentrum Weser Prof. Dr. med. Schmitz Minden |
Accredited | ja |
More Results for the letter A
- Angina Plaut-Vincenti (APV)
- Treponema vincentii and fusobacterium nucleatum
- ANP (ANP)
- atrial natriuretic peptide
- Anti-actin autoantibodies (ACTIN)
- Anti-alpha fodrin autoantibodies (AFODG)
- Anti-desmoglein 1/3 (DESMO)
- Anti-DNA antibodies (DNADS)
- ds-DNA antibodies (double-stranded)
- Anti-epidermal basal membrane (EPI)
- Anti-goblet cell autoantibodies (BECZE)
- Anti-mitochondrial antibodies (AMA)
- AMA and AMA subtype 2
- Anti-mullarian hormone (AMH)
- Anti-sickle cell desmosomes (STADE)
- Anti-SP100 (SP100)
- multiple nuclear dots
- Antibiogram (ANTIBIO)
- Antibodies against α-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid receptor (AMPAR)
- Antibodies against adenylate kinase 5 (Ak5)
- Ak5
- Antibodies against contactin-associated protein 2 (CASPR2)
- Antibodies against ganglionic (alpha-3) acetylcholine receptors (gAChR)
- (gAChR)
- Antibodies against glutamate decarboxylase 65 kDa (GAD65)
- Antibodies against leucine-rich glioma inactivated protein 1 (LGI1)
- Antibodies against LRP4
- (low-density lipoprotein receptor-related protein 4)
- Antibodies against myelin oligodendrocyte glycoprotein (MOG)
- Antibodies against N-methyl-D-aspartate receptor receptors (NMDAR)
- Antibodies against oxidized LDL (LDLOX)
- Antibodies against the γ-aminobutyric acid A receptor (GABA-A-R)
- Antibodies against the γ-aminobutyric acid B receptor (GABA-B-R)
- Antibodies against the glial fibrillary acidic protein (GFAP)
- Antibodies against the glycine receptor (GlyR)
- Antibodies against the metabotropic glutamate receptor type 1 (mGluR1 antibodies)
- Antibody screen (ANTI01)
- Antibody screening (AK)
- AKS